Jecure Therapeutics, Inc. — Form D
Jecure Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-22. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-02-22
- Form: D
- Accession: 0001698655-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Remaining: $2K
- Investors: 4
- Date of first sale: 2017-02-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-281127
Issuer
- Name: Jecure Therapeutics, Inc.
- CIK: 0001698655
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 4757 Nexus Center Drive, Suite 150, SAN DIEGO, CA, 92121
- Phone: 619-541-8694
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jeffrey Stafford, Ph.D. | Director | San Diego, CA |
| Jeffrey Stafford, Ph.D. | Executive Officer | San Diego, CA |
| Thomas Woiwode, Ph.D. | Director | San Francisco, CA |
| Bradley Bolzon, Ph.D. | Director | San Diego, CA |
| Ariel Feldstein, M.D. | Director | San Diego, CA |
| James Veal, Ph.D. | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More